Hylase Wound Gel
Generic Name: sodium hyaluronate
Dosage Form: gel
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Hylase Wound Gel
For External Use Only
Description: Hylase Wound Gel is formulated to provide wound care dressing and management.
Hylase Wound Gel is a combination of emollients and sodium hyaluronate which function to maintain tissue hydration and support the healing process. Hylase Wound Gel has been demonstrated to be of value in the management of certain skin ulcers and wounds. Sodium hyaluronate is a salt of hyaluronic acid, a naturallyoccuring molecule found in various body tissues. The sodium hyaluronate present in Hylase Wound Gel is synthetically derived.
Ingredients: Sodium Hyaluronate (2.5 %), Hydroxyethylcellulose, Methylparaben, Polyethylene Glycol, Water
- Hylase Wound Gel is for external use only.
- If signs of infection become present, consult a physician
- Keep this and all medications out of the reach of children.
Appropriate supportive measures should be taken where indicated, e.g. the use of graduated compression bandaging in the management of venous leg ulcers, or pressure relief measures in the management of pressure ulcers. The control of blood glucose as well as appropriate advice regarding pressure relief measures should be provided to patients with diabetic foot ulcers. Colonization of chronic wounds is common and the use of Hylase Wound Gel is not contraindicated. Hylase Wound Gel may be used on infected wounds under medical supervision and in conjunction with other appropriate therapy and frequent monitoring of the wound by the healthcare professional.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN
Hylase Wound Gel covered by Patent Nos.
5,897,880, 6,063,405, 6,120,804, and 6,335,035.
ECR Pharmaceuticals Co., Inc.
Richmond, Virginia 23255
Great Southern Laboratories
Houston, Texas 77099
Product PackagingThe packaging below represents the current tube labeling used.
Principal display panel for 75 g tubing:
75g NDC 0095-0073-75
Wound Gel Only
FOR EXTERNAL USE ONLY
Contents: Sodium Hyaluronate (2.5%), Hydroxyethylcellulose, Methylparaben,
Polyethylene Glycol, Water.
Manufactured for: ECR ECR Pharmaceuticals Co., Inc.
Richmond, VA 23255
Storage: Store at 15°- 30°C (59°- 86°F) in a dry place. Do not freeze or expose to
temperatures above 35°C (95°F).
Usual Application: Once daily with appropriate cleaning and dressing of wound.
See accompanying package insert for details. Do not use if tamper
evident foil seal is broken or missing.
Lot number and expiry date are located on crimped end of tube.
Hylase® Wound Gel covered by Patent Nos.
5,897,880 · 6,063,405 · 6,120,804 · 6,335,035
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
ML 0073 Rev 05/2011
sodium hyaluronate gel
|Labeler - ECR Pharmaceuticals Co., Inc. (831116350)|
|Registrant - Great Southern Laboratories (056139553)|
|Great Southern Laboratories||056139553||manufacture|
More Hylase Wound Gel resources
- Hylase Wound Gel topical Concise Consumer Information (Cerner Multum)
- Bionect cream MedFacts Consumer Leaflet (Wolters Kluwer)
- Gelclair gel MedFacts Consumer Leaflet (Wolters Kluwer)
- Hylira gel MedFacts Consumer Leaflet (Wolters Kluwer)